Selected research
Market Analysis & Forecast
Global DNA/RNA Quality Control Market Analysis and Forecast 2026-2032
Market perspective
The global DNA/RNA Quality Control market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for DNA/RNA Quality Control is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for DNA/RNA Quality Control is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for DNA/RNA Quality Control is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for DNA/RNA Quality Control is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of DNA/RNA Quality Control include BigOmics Analytics, Cambridge Genomic Services, Creative Biogene, Eurofins Genomics, Genomics, Hokkaido System Science, LC Sciences, Life Magnetics and Norgen Biotek, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for DNA/RNA Quality Control, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of DNA/RNA Quality Control, also provides the revenue of main regions and countries. Of the upcoming market potential for DNA/RNA Quality Control, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the DNA/RNA Quality Control revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global DNA/RNA Quality Control market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for DNA/RNA Quality Control revenue, projected growth trends, production technology, application and end-user industry.
DNA/RNA Quality Control Segment by Company
BigOmics Analytics
Cambridge Genomic Services
Creative Biogene
Eurofins Genomics
Genomics
Hokkaido System Science
LC Sciences
Life Magnetics
Norgen Biotek
Omega Bioservices
PathoQuest
QIAGEN
QIMA Life Sciences
Thermo Fisher Scientific
DNA/RNA Quality Control Segment by Type
DNA Quality Control
RNA Quality Control
DNA/RNA Quality Control Segment by Application
Medical Diagnostics
Biological Research
Genomics
DNA/RNA Quality Control Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA/RNA Quality Control market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA/RNA Quality Control and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA/RNA Quality Control.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of DNA/RNA Quality Control in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of DNA/RNA Quality Control company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA/RNA Quality Control revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Quality Control
- RNA Quality Control
Applications
- Medical Diagnostics
- Biological Research
- Genomics
Companies covered
- BigOmics Analytics
- Cambridge Genomic Services
- Creative Biogene
- Eurofins Genomics
- Genomics
- Hokkaido System Science
- LC Sciences
- Life Magnetics
- Norgen Biotek
- Omega Bioservices
- PathoQuest
- QIAGEN
- QIMA Life Sciences
- Thermo Fisher Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 DNA/RNA Quality Control Market by Type
- 1.2.1 Global DNA/RNA Quality Control Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 DNA Quality Control
- 1.2.3 RNA Quality Control
- 1.3 DNA/RNA Quality Control Market by Application
- 1.3.1 Global DNA/RNA Quality Control Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Medical Diagnostics
- 1.3.3 Biological Research
- 1.3.4 Genomics
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 DNA/RNA Quality Control Market Dynamics
- 2.1 DNA/RNA Quality Control Industry Trends
- 2.2 DNA/RNA Quality Control Industry Drivers
- 2.3 DNA/RNA Quality Control Industry Opportunities and Challenges
- 2.4 DNA/RNA Quality Control Industry Restraints
3 Global Growth Perspective
- 3.1 Global DNA/RNA Quality Control Market Perspective (2021-2032)
- 3.2 Global DNA/RNA Quality Control Growth Trends by Region
- 3.2.1 Global DNA/RNA Quality Control Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global DNA/RNA Quality Control Market Size by Region (2021-2026)
- 3.2.3 Global DNA/RNA Quality Control Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global DNA/RNA Quality Control Revenue by Players
- 4.1.1 Global DNA/RNA Quality Control Revenue by Players (2021-2026)
- 4.1.2 Global DNA/RNA Quality Control Revenue Market Share by Players (2021-2026)
- 4.1.3 Global DNA/RNA Quality Control Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global DNA/RNA Quality Control Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global DNA/RNA Quality Control Key Players Headquarters & Area Served
- 4.4 Global DNA/RNA Quality Control Players, Product Type & Application
- 4.5 Global DNA/RNA Quality Control Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global DNA/RNA Quality Control Market CR5 and HHI
- 4.6.3 2025 DNA/RNA Quality Control Tier 1, Tier 2, and Tier 3
5 DNA/RNA Quality Control Market Size by Type
- 5.1 Global DNA/RNA Quality Control Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global DNA/RNA Quality Control Revenue by Type (2021-2032)
- 5.3 Global DNA/RNA Quality Control Revenue Market Share by Type (2021-2032)
6 DNA/RNA Quality Control Market Size by Application
- 6.1 Global DNA/RNA Quality Control Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global DNA/RNA Quality Control Revenue by Application (2021-2032)
- 6.3 Global DNA/RNA Quality Control Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 BigOmics Analytics
- 7.1.1 BigOmics Analytics Company Information
- 7.1.2 BigOmics Analytics Business Overview
- 7.1.3 BigOmics Analytics DNA/RNA Quality Control Revenue and Gross Margin (2021-2026)
- 7.1.4 BigOmics Analytics DNA/RNA Quality Control Product Portfolio
- 7.1.5 BigOmics Analytics Recent Developments
- 7.2 Cambridge Genomic Services
- 7.2.1 Cambridge Genomic Services Company Information
- 7.2.2 Cambridge Genomic Services Business Overview
- 7.2.3 Cambridge Genomic Services DNA/RNA Quality Control Revenue and Gross Margin (2021-2026)
- 7.2.4 Cambridge Genomic Services DNA/RNA Quality Control Product Portfolio
- 7.2.5 Cambridge Genomic Services Recent Developments
- 7.3 Creative Biogene
- 7.3.1 Creative Biogene Company Information
- 7.3.2 Creative Biogene Business Overview
- 7.3.3 Creative Biogene DNA/RNA Quality Control Revenue and Gross Margin (2021-2026)
- 7.3.4 Creative Biogene DNA/RNA Quality Control Product Portfolio
- 7.3.5 Creative Biogene Recent Developments
- 7.4 Eurofins Genomics
- 7.4.1 Eurofins Genomics Company Information
- 7.4.2 Eurofins Genomics Business Overview
- 7.4.3 Eurofins Genomics DNA/RNA Quality Control Revenue and Gross Margin (2021-2026)
- 7.4.4 Eurofins Genomics DNA/RNA Quality Control Product Portfolio
- 7.4.5 Eurofins Genomics Recent Developments
- 7.5 Genomics
- 7.5.1 Genomics Company Information
- 7.5.2 Genomics Business Overview
- 7.5.3 Genomics DNA/RNA Quality Control Revenue and Gross Margin (2021-2026)
- 7.5.4 Genomics DNA/RNA Quality Control Product Portfolio
- 7.5.5 Genomics Recent Developments
- 7.6 Hokkaido System Science
- 7.6.1 Hokkaido System Science Company Information
- 7.6.2 Hokkaido System Science Business Overview
- 7.6.3 Hokkaido System Science DNA/RNA Quality Control Revenue and Gross Margin (2021-2026)
- 7.6.4 Hokkaido System Science DNA/RNA Quality Control Product Portfolio
- 7.6.5 Hokkaido System Science Recent Developments
- 7.7 LC Sciences
- 7.7.1 LC Sciences Company Information
- 7.7.2 LC Sciences Business Overview
- 7.7.3 LC Sciences DNA/RNA Quality Control Revenue and Gross Margin (2021-2026)
- 7.7.4 LC Sciences DNA/RNA Quality Control Product Portfolio
- 7.7.5 LC Sciences Recent Developments
- 7.8 Life Magnetics
- 7.8.1 Life Magnetics Company Information
- 7.8.2 Life Magnetics Business Overview
- 7.8.3 Life Magnetics DNA/RNA Quality Control Revenue and Gross Margin (2021-2026)
- 7.8.4 Life Magnetics DNA/RNA Quality Control Product Portfolio
- 7.8.5 Life Magnetics Recent Developments
- 7.9 Norgen Biotek
- 7.9.1 Norgen Biotek Company Information
- 7.9.2 Norgen Biotek Business Overview
- 7.9.3 Norgen Biotek DNA/RNA Quality Control Revenue and Gross Margin (2021-2026)
- 7.9.4 Norgen Biotek DNA/RNA Quality Control Product Portfolio
- 7.9.5 Norgen Biotek Recent Developments
- 7.10 Omega Bioservices
- 7.10.1 Omega Bioservices Company Information
- 7.10.2 Omega Bioservices Business Overview
- 7.10.3 Omega Bioservices DNA/RNA Quality Control Revenue and Gross Margin (2021-2026)
- 7.10.4 Omega Bioservices DNA/RNA Quality Control Product Portfolio
- 7.10.5 Omega Bioservices Recent Developments
- 7.11 PathoQuest
- 7.11.1 PathoQuest Company Information
- 7.11.2 PathoQuest Business Overview
- 7.11.3 PathoQuest DNA/RNA Quality Control Revenue and Gross Margin (2021-2026)
- 7.11.4 PathoQuest DNA/RNA Quality Control Product Portfolio
- 7.11.5 PathoQuest Recent Developments
- 7.12 QIAGEN
- 7.12.1 QIAGEN Company Information
- 7.12.2 QIAGEN Business Overview
- 7.12.3 QIAGEN DNA/RNA Quality Control Revenue and Gross Margin (2021-2026)
- 7.12.4 QIAGEN DNA/RNA Quality Control Product Portfolio
- 7.12.5 QIAGEN Recent Developments
- 7.13 QIMA Life Sciences
- 7.13.1 QIMA Life Sciences Company Information
- 7.13.2 QIMA Life Sciences Business Overview
- 7.13.3 QIMA Life Sciences DNA/RNA Quality Control Revenue and Gross Margin (2021-2026)
- 7.13.4 QIMA Life Sciences DNA/RNA Quality Control Product Portfolio
- 7.13.5 QIMA Life Sciences Recent Developments
- 7.14 Thermo Fisher Scientific
- 7.14.1 Thermo Fisher Scientific Company Information
- 7.14.2 Thermo Fisher Scientific Business Overview
- 7.14.3 Thermo Fisher Scientific DNA/RNA Quality Control Revenue and Gross Margin (2021-2026)
- 7.14.4 Thermo Fisher Scientific DNA/RNA Quality Control Product Portfolio
- 7.14.5 Thermo Fisher Scientific Recent Developments
8 North America
- 8.1 North America DNA/RNA Quality Control Revenue (2021-2032)
- 8.2 North America DNA/RNA Quality Control Revenue by Type (2021-2032)
- 8.2.1 North America DNA/RNA Quality Control Revenue by Type (2021-2026)
- 8.2.2 North America DNA/RNA Quality Control Revenue by Type (2027-2032)
- 8.3 North America DNA/RNA Quality Control Revenue Share by Type (2021-2032)
- 8.4 North America DNA/RNA Quality Control Revenue by Application (2021-2032)
- 8.4.1 North America DNA/RNA Quality Control Revenue by Application (2021-2026)
- 8.4.2 North America DNA/RNA Quality Control Revenue by Application (2027-2032)
- 8.5 North America DNA/RNA Quality Control Revenue Share by Application (2021-2032)
- 8.6 North America DNA/RNA Quality Control Revenue by Country
- 8.6.1 North America DNA/RNA Quality Control Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America DNA/RNA Quality Control Revenue by Country (2021-2026)
- 8.6.3 North America DNA/RNA Quality Control Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe DNA/RNA Quality Control Revenue (2021-2032)
- 9.2 Europe DNA/RNA Quality Control Revenue by Type (2021-2032)
- 9.2.1 Europe DNA/RNA Quality Control Revenue by Type (2021-2026)
- 9.2.2 Europe DNA/RNA Quality Control Revenue by Type (2027-2032)
- 9.3 Europe DNA/RNA Quality Control Revenue Share by Type (2021-2032)
- 9.4 Europe DNA/RNA Quality Control Revenue by Application (2021-2032)
- 9.4.1 Europe DNA/RNA Quality Control Revenue by Application (2021-2026)
- 9.4.2 Europe DNA/RNA Quality Control Revenue by Application (2027-2032)
- 9.5 Europe DNA/RNA Quality Control Revenue Share by Application (2021-2032)
- 9.6 Europe DNA/RNA Quality Control Revenue by Country
- 9.6.1 Europe DNA/RNA Quality Control Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe DNA/RNA Quality Control Revenue by Country (2021-2026)
- 9.6.3 Europe DNA/RNA Quality Control Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China DNA/RNA Quality Control Revenue (2021-2032)
- 10.2 China DNA/RNA Quality Control Revenue by Type (2021-2032)
- 10.2.1 China DNA/RNA Quality Control Revenue by Type (2021-2026)
- 10.2.2 China DNA/RNA Quality Control Revenue by Type (2027-2032)
- 10.3 China DNA/RNA Quality Control Revenue Share by Type (2021-2032)
- 10.4 China DNA/RNA Quality Control Revenue by Application (2021-2032)
- 10.4.1 China DNA/RNA Quality Control Revenue by Application (2021-2026)
- 10.4.2 China DNA/RNA Quality Control Revenue by Application (2027-2032)
- 10.5 China DNA/RNA Quality Control Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia DNA/RNA Quality Control Revenue (2021-2032)
- 11.2 Asia DNA/RNA Quality Control Revenue by Type (2021-2032)
- 11.2.1 Asia DNA/RNA Quality Control Revenue by Type (2021-2026)
- 11.2.2 Asia DNA/RNA Quality Control Revenue by Type (2027-2032)
- 11.3 Asia DNA/RNA Quality Control Revenue Share by Type (2021-2032)
- 11.4 Asia DNA/RNA Quality Control Revenue by Application (2021-2032)
- 11.4.1 Asia DNA/RNA Quality Control Revenue by Application (2021-2026)
- 11.4.2 Asia DNA/RNA Quality Control Revenue by Application (2027-2032)
- 11.5 Asia DNA/RNA Quality Control Revenue Share by Application (2021-2032)
- 11.6 Asia DNA/RNA Quality Control Revenue by Country
- 11.6.1 Asia DNA/RNA Quality Control Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia DNA/RNA Quality Control Revenue by Country (2021-2026)
- 11.6.3 Asia DNA/RNA Quality Control Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA DNA/RNA Quality Control Revenue (2021-2032)
- 12.2 SAMEA DNA/RNA Quality Control Revenue by Type (2021-2032)
- 12.2.1 SAMEA DNA/RNA Quality Control Revenue by Type (2021-2026)
- 12.2.2 SAMEA DNA/RNA Quality Control Revenue by Type (2027-2032)
- 12.3 SAMEA DNA/RNA Quality Control Revenue Share by Type (2021-2032)
- 12.4 SAMEA DNA/RNA Quality Control Revenue by Application (2021-2032)
- 12.4.1 SAMEA DNA/RNA Quality Control Revenue by Application (2021-2026)
- 12.4.2 SAMEA DNA/RNA Quality Control Revenue by Application (2027-2032)
- 12.5 SAMEA DNA/RNA Quality Control Revenue Share by Application (2021-2032)
- 12.6 SAMEA DNA/RNA Quality Control Revenue by Country
- 12.6.1 SAMEA DNA/RNA Quality Control Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA DNA/RNA Quality Control Revenue by Country (2021-2026)
- 12.6.3 SAMEA DNA/RNA Quality Control Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst